FDA Grants Mesoblast Fast Track Designation For GVHD
Filed with ASX · · 2 pages · English
Story so far
Earlier from Mesoblast
- Positive Nine Month RA Results For Mesoblast Cell Therapy
- Published Results Show MSB Cells Effective In RA Model
- Mesoblast Director Recognized For Cardiovascular Leadership
- Mesoblast And Mallinckrodt Enter Into Agreement
- MD Anderson and NIH Fund Trial Using Mesoblast Technologies
Later from Mesoblast
- Durable Three Year Outcomes in Disc Disease
- Mesoblast Raises US$40 Million
- Process Initiated For CHF P3 Interim Analysis
- FDA Clears Heart Disease Trial At Boston Childrens Hospital
- Mesoblast Receives A$3.7m From Aus Govt For R&D
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast